Xerostomia Due to Radiotherapy: Clinical Trials

10 trials for Xerostomia Due to Radiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 unknown, 2 not yet recruiting. 4 Not applicable, 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Not yet recruiting 1, Unknown 1
Phase 13Unknown 2, Completed 1
Phase 23Unknown 2, Not yet recruiting 1

Follow Xerostomia Due to Radiotherapy: new trials by email Literature Review of Xerostomia Due to Radiotherapy trials Research Report on Xerostomia Due to Radiotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy
ORAL CARE PRODUCT KIT - Head and Neck Cancer (H&N), Oral Mucositis (Ulcerative) Due to Radiation
Not applicableNot yet recruitingUNCANCER LLC502026-11-012026-10-21
Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors
ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, Placebo - Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy
Phase 2Not yet recruitingChristian von Buchwald1002025-12-012025-12-18
Prevalence of Late Xerostomia and Hyposalivation with Associated Risk Factors in Survivors of Head and Neck Cancer After Radiotherapy: a Multi-centric Cross-sectional Study
Radiotherapy Side Effect, Xerostomia Due to Radiotherapy
CompletedAin Shams University2602023-03-202025-02-28
Mesenchymal Stem Cells for Radiation-induced Xerostomia
Autologous adipose-derived mesenchymal stem/stromal cells, Placebo - Radiation Toxicity, Xerostomia Due to Radiotherapy
Phase 1 / Phase 2UnknownCopenhagen University Hospital, Rigshospitalet302020-08-012020-10-22
MRI - Guided Adaptive RadioTHerapy for Reducing XerostomiA in Head and Neck Cancer (MARTHA-trial)
Pre-defined MR-linac based IGRT and plan adaptation protocol, salivary flow measurements - Head and Neck Cancer, Xerostomia Due to Radiotherapy
Not applicableCompletedPanagiotis Balermpas492019-10-152026-08-03
A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia
AAV2hAQP1: 1 x 10^11 vg/gland (single gland), AAV2hAQP1: 3 x 10^10 vg/gland (both glands), AAV2hAQP1: 3 x 10^11 vg/gland (single gland) - Radiation-Induced Parotid Gland Hypofunction, Xerostomia Due to Radiotherapy
Phase 1CompletedMeiraGTx UK II Ltd242019-06-302023-04-24
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
Allogeneic adipose derived stem/stromal cells - Xerostomia Due to Radiotherapy, Hyposalivation
Phase 1UnknownCopenhagen University Hospital, Rigshospitalet102019-03-182021-01-29
Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy
mesenchymal cells - Xerostomia Due to Radiotherapy
Phase 2UnknownInstitut de Terapia Regenerativa Tissular102018-12-152018-11-16
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
Finger-prick Autologous Blood (FAB) - Xerostomia, Xerostomia Due to Radiotherapy
Not applicableUnknownBedford Hospital NHS Trust202018-09-012018-07-27
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
Parotid-Sparing Head & Neck Radiation Guided by MRI Sialography - Head and Neck Cancer, Oropharynx Cancer
Not applicableCompletedUNC Lineberger Comprehensive Cancer Center402018-03-082023-05-31

Narrower conditions

Head and Neck Neoplasms (5)  ·  Xerostomia (5)  ·  Radiation Injuries (3)  ·  Oropharyngeal Neoplasms (2)  ·  Long Term Adverse Effects (1)  ·  Neoplasms (1)  ·  Salivary Gland Diseases (1)  ·  Sjogren's Syndrome (1)  ·  Stomatitis (1)  ·  Ulcer (1)

Broader conditions

Stomatognathic Diseases (7)  ·  Mouth Diseases (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Salivary Gland Diseases (4)  ·  Wounds and Injuries (3)  ·  Otorhinolaryngologic Diseases (2)  ·  Otorhinolaryngologic Neoplasms (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pharyngeal Diseases (2)  ·  Pharyngeal Neoplasms (2)  ·  Arthritis (1)  ·  Arthritis, Rheumatoid (1)  ·  Autoimmune Diseases (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (2)  ·  Ain Shams University (1)  ·  Bedford Hospital NHS Trust (1)  ·  Christian von Buchwald (1)  ·  Institut de Terapia Regenerativa Tissular (1)  ·  MeiraGTx UK II Ltd (1)  ·  Panagiotis Balermpas (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  UNCANCER LLC (1)

Countries

United States (3)  ·  Denmark (2)  ·  Canada (1)  ·  Egypt (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Charlotte Lynggaard, MD (2)  ·  Christian von Buchwald, MD, Professor (1)  ·  David V. Fried, PhD (1)  ·  Panagiotis Balermpas, M.D. (1)

NIH funding

2014 (1), 2018 (1), 2025 (1)